AAPL 207.5 +0.52 (+0.25%)MSFT 125.42 +0.48 (+0.38%)FB 183.67 +0.21 (+0.11%)ZNGA 5.62 +0.1 (+1.81%)NVDA 190.7 -0.66 (-0.34%)WBA 53.19 -0.53 (-0.99%)GOOG 1264.39 -1.93 (-0.15%)PIH 5.25 -0.05 (-0.94%)
AAPL 207.5 +0.52 (+0.25%)MSFT 125.42 +0.48 (+0.38%)FB 183.67 +0.21 (+0.11%)ZNGA 5.62 +0.1 (+1.81%)NVDA 190.7 -0.66 (-0.34%)WBA 53.19 -0.53 (-0.99%)GOOG 1264.39 -1.93 (-0.15%)PIH 5.25 -0.05 (-0.94%)

Balance Sheet ABMD Quote ABIOMED Inc

All | Income Statement | Balance Sheet | Cash Flow | Retained Earnings | PPE Schedule | Intangible and Goodwill Schedule
Year 201420152016
CashAndCashEqui 48 39 43
ShortTermInvest 164 191 319
Cash 212 230 362
AccountReceivab 43 54 70
Inventories 27 35 50
DeferredIncomeT 59 35 71
OtherCurrentAss 0 0 0
TotalCurrentAss 288 327 494
PPE 42 108 145
AccumulatedDepr -19 -20 -28
NetPPE 23 88 117
EquityAndOtherI 1 47 38
Goodwill 33 31 36
IntangibleAsset 15 14 17
OtherLTAssets 4 8 14
TotalNonCurrent 136 223 292
TotalAssets 424 550 786
ShortTermDebt 0 0 0
AccountsPayable 9 21 24
TaxesPayable 3 3 5
AccruedLiabilit 7 11 11
DeferredRevenue 9 10 15
OtherCurrentLia 18 23 30
TotalCurrentLia 47 70 85
Debt 0 0 0
DeferredTaxesLi 1 1 1
DeferredRevenue 0 0 0
OtherLTLiabilit 8 12 11
TotalNonCurrent 9 29 12
TotalLiabilitie 55 98 97
CommonStock 0 0 0
AdditionalPaidI 509 566 620
RetainedEarning -99 -47 140
AccumulatedOthe -15 -21 -4
TotalStockholde 369 452 690
TotalLiabilitie 424 550 786
ABIOMED Inc. income statement is the only one that provides an overview of company sales and net income
The reasoning behind the adjustment, however, is that free cash flow is meant to measure money being spent right now, not transactions that happened in the past. This makes ABIOMED Inc. FCF a useful instrument for identifying growing companies with high up-front costs, which may eat into earnings now but have the potential to pay off later.